Publications by authors named "Bridget A Quinn"

Claim this Profile
C
Correlates of Deliberate Self-Harm in Youth With Autism and/or Intellectual Disability.
Carmen Lopez-Arvizu, Danielle L Steelesmith, Brittany N Hand, Rui Huang, Amanda J Thompson, Bridget A Quinn

JAACAP Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in vaginal length and sexual function in women who undergo surgery ± radiation therapy for endometrial cancer.
Bridget A Quinn, Xiaoyan Deng, Stephanie A Sullivan, Jori Carter, Dipankar Bandyopadhyay

Brachytherapy· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The vaginal cylinder: Misunderstood, misused, or trivial? An in-depth dosimetric and multiinstitutional outcome investigation.
Christopher L Guy, Emma C Fields, Bridget A Quinn, Christine M Fisher, Colton J Ladbury

Brachytherapy· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Bridget A Quinn, Xiaoyan Deng, Adrianne Colton, Dipankar Bandyopadhyay, Jori S Carter

Brachytherapy· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Quest for an Effective Treatment for an Intractable Cancer: Established and Novel Therapies for Pancreatic Adenocarcinoma.
Bridget A Quinn, Nathaniel A Lee, Timothy P Kegelman, Praveen Bhoopathi, Luni Emdad

Adv Cancer Res· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine.
Bridget A Quinn, Si Wang, Elisa Barile, Swadesh K Das, Luni Emdad

Oncotarget· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells.
Bainan Wu, Si Wang, Surya K De, Elisa Barile, Bridget A Quinn

Chem Biol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
Santanu Maji, Sabindra K Samal, Laxmipriya Pattanaik, Swagatika Panda, Bridget A Quinn

Oncotarget· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline.
Bridget A Quinn, Rupesh Dash, Siddik Sarkar, Belal Azab, Praveen Bhoopathi

Cancer Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic.
Siddik Sarkar, Bridget A Quinn, Xue-Ning Shen, Rupesh Dash, Swadesh K Das

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approach.
Siddik Sarkar, Bridget A Quinn, Xuening Shen, Paul Dent, Swadesh K Das

Mol Pharmacol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid.
Praveen Bhoopathi, Bridget A Quinn, Qin Gui, Xue-Ning Shen, Steven R Grossman

Cancer Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).
Belal M Azab, Rupesh Dash, Swadesh K Das, Sujit K Bhutia, Siddik Sarkar, Bridget A Quinn

J Cell Physiol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Bcl-2 family for cancer therapy.
Shibu Thomas, Bridget A Quinn, Swadesh K Das, Rupesh Dash, Luni Emdad

Expert Opin Ther Targets· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules.
Michael Hedvat, Luni Emdad, Swadesh K Das, Keetae Kim, Santanu Dasgupta, Bridget A Quinn

Anticancer Agents Med Chem· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.
Belal Azab, Rupesh Dash, Swadesh K Das, Sujit K Bhutia, Xue-Ning Shen, Bridget A Quinn

J Cell Physiol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDA-9/syntenin: a positive gatekeeper of melanoma metastasis.
Swadesh K Das, Sujit K Bhutia, Timothy P Kegelman, Leyla Peachy, Regina A Oyesanya, Bridget A Quinn

Front Biosci (Landmark Ed)· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Mcl-1 for the therapy of cancer.
Bridget A Quinn, Rupesh Dash, Belal Azab, Siddik Sarkar, Swadesh K Das

Expert Opin Investig Drugs· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity.
Rupesh Dash, Belal Azab, Bridget A Quinn, Xuening Shen, Xiang-Yang Wang

Proc Natl Acad Sci U S A· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicity.
Rupesh Dash, Sujit K Bhutia, Belal Azab, Zhao-zhong Su, Bridget A Quinn

Cytokine Growth Factor Rev· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a syngeneic mouse model of epithelial ovarian cancer.
Bridget A Quinn, Fang Xiao, Laura Bickel, Lainie Martin, Xiang Hua

J Ovarian Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53.
Bridget A Quinn, Tiffany Brake, Xiang Hua, Kimberly Baxter-Jones, Samuel Litwin

PLoS One· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance imaging for detection and determination of tumor volume in a genetically engineered mouse model of ovarian cancer.
Harvey Hensley, Bridget A Quinn, Ronald L Wolf, Samuel L Litwin, Seiji Mabuchi

Cancer Biol Ther· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis